WESPAC Advisors SoCal LLC boosted its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 5.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,025 shares of the company’s stock after acquiring an additional 1,946 shares during the period. Procter & Gamble makes up approximately 1.6% of WESPAC Advisors SoCal LLC’s holdings, making the stock its 23rd largest holding. WESPAC Advisors SoCal LLC’s holdings in Procter & Gamble were worth $6,932,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble during the second quarter worth about $29,000. POM Investment Strategies LLC acquired a new stake in Procter & Gamble during the second quarter valued at approximately $34,000. Quest Partners LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $36,000. Finally, Fairfield Financial Advisors LTD bought a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $44,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In other news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. The trade was a 25.95 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total value of $16,320,000.00. Following the sale, the chief executive officer now directly owns 13,721 shares in the company, valued at $2,332,570. The trade was a 87.49 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 313,597 shares of company stock worth $53,268,499 in the last ninety days. Company insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Up 1.5 %
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the previous year, the business earned $1.83 EPS. The business’s quarterly revenue was down .6% compared to the same quarter last year. On average, sell-side analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. Procter & Gamble’s payout ratio is currently 69.48%.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the company. Stifel Nicolaus increased their price objective on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research note on Monday, July 22nd. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. DA Davidson boosted their price target on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research report on Monday, October 21st. Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a report on Monday, September 30th. Finally, StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Nine equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $177.00.
View Our Latest Stock Report on PG
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Comparing and Trading High PE Ratio Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Makes a Stock a Good Dividend Stock?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.